These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 8567061)

  • 21. Angiotensin-I converting enzyme (ACE) gene polymorphism and the erythrocyte sodium-lithium countertransport in hypertension.
    Delanghe J; De Buyzere M; Wuyts B; Tournoy K; Duprez D; Clement D
    J Hum Hypertens; 1997 Apr; 11(4):251-2. PubMed ID: 9185032
    [No Abstract]   [Full Text] [Related]  

  • 22. Sodium-lithium countertransport activity in healthy, dyslipidemic, and hypertensive individuals.
    Savopoulos CG; Hatzitolios AI; Katsiki NA; Baltatzi M; Kosmidou M; Raikos N; Mikhailidis DP; Ziakas AG; Kaiafa G; Tsesmeli N
    Angiology; 2008 Dec-2009 Jan; 59(6):727-35. PubMed ID: 18840623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erythrocyte Na(+)-Li+ countertransport in essential hypertension: correlation with membrane lipids levels.
    Villar J; Montilla C; Muñiz-Grijalvo O; Muriana FG; Stiefel P; Ruiz-Gutiérrez V; Carneado J
    J Hypertens; 1996 Aug; 14(8):969-73. PubMed ID: 8884551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced Na-Li countertransport: a marker of inherited susceptibility to type 2 diabetes.
    Vaccaro O; Cuomo V; Trevisan M; Cirillo M; Panarelli W; Laurenzi M; Mancini M; Riccardi G;
    Int J Epidemiol; 2005 Oct; 34(5):1123-8. PubMed ID: 16087689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Na-Li countertransport and blood pressure in childhood.
    Trevisan M; Borrillo J
    Child Nephrol Urol; 1992; 12(2-3):85-9. PubMed ID: 1628276
    [No Abstract]   [Full Text] [Related]  

  • 26. Enhanced activity of sodium-lithium countertransport in patients with cardiac syndrome X: a potential link between cardiac and metabolic syndrome X.
    Hardman TC; Clifford RH; Dubrey SW
    J Am Coll Cardiol; 1999 Sep; 34(3):955-7. PubMed ID: 10483984
    [No Abstract]   [Full Text] [Related]  

  • 27. Relation of sodium-lithium countertransport activity to markers of cardiovascular risk in normotensive subjects.
    Hardman TC; Dubrey SW; Soni S; Lant AF
    J Hum Hypertens; 1995 Jul; 9(7):589-96. PubMed ID: 7562890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of sodium-lithium countertransport kinetics.
    Hardman T; Lant A
    Hypertension; 1996 Feb; 27(2):314-5; author reply 315-6. PubMed ID: 8567060
    [No Abstract]   [Full Text] [Related]  

  • 29. Measurement of sodium-lithium countertransport kinetics.
    Thomas TH; West IC; Rutherford PA
    Hypertension; 1996 Feb; 27(2):313-4; author reply 316. PubMed ID: 8567059
    [No Abstract]   [Full Text] [Related]  

  • 30. Altered membrane microviscosity in essential hypertension: relationship with family history of hypertension and sodium-lithium countertransport activity.
    Carr SJ; Sikand K; Moore D; Norman RI
    J Hypertens; 1995 Jan; 13(1):139-46. PubMed ID: 7759844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erythrocyte membrane cholesterol distribution in patients with untreated essential hypertension: correlation with sodium-lithium countertransport.
    Muriana FJ; Villar J; Ruíz-Gutiérrez V
    J Hypertens; 1996 Apr; 14(4):443-6. PubMed ID: 8761892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and epidemiological studies on electrolyte transport systems in hypertension.
    Williams RR; Hunt SC; Wu LL; Hasstedt SJ; Hopkins PN; Ash KO
    Clin Physiol Biochem; 1988; 6(3-4):136-49. PubMed ID: 3060295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of sodium-lithium countertransport kinetics.
    Wierzbicki AS
    Hypertension; 1996 Feb; 27(2):315; author reply 316. PubMed ID: 8567061
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.